These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6683547)

  • 1. [Effect of xanthinol nicotinate on brain metabolism in rats].
    Brenner G
    Arzneimittelforschung; 1983; 33(5):698-701. PubMed ID: 6683547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of xantinol-nicotinate on brain metabolism. Experimental animal study of the effect on glucose-C 14 permeation and pyridine and adenone nucleotides].
    Brenner G; Brenner H
    Arzneimittelforschung; 1972 Apr; 22(4):754-9. PubMed ID: 4340340
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR; Kogel H
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation and structure determination of metabolites of xantinol from rat urine (author's transl)].
    Tauscher M; Eckhardt G; Geisel B; Credner K
    Arzneimittelforschung; 1976; 26(7):1342-4. PubMed ID: 1036921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Xanthinol nicotinate and wound healing].
    Benfer J; Struck H
    Arzneimittelforschung; 1978; 28(1):37-41. PubMed ID: 580195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The reactions of embryonic tissues and cells to xantinol-nicotinate in the culture (author's transl)].
    Lipp VR
    Arzneimittelforschung; 1976; 26(5):759-64. PubMed ID: 989348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B; Molnár L; Demeter J; Túry F
    Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the oxidative glucose brain metabolism under long-term xantinol-nicotinate medication (author's transl)].
    Quadbeck H; Lehmann E
    Arzneimittelforschung; 1978; 28(9):1531-2. PubMed ID: 582552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of xanthinol nicotinate (complamin).
    Galal E; Moustafa M; el-Gohary N; el-Mahdy SA; el-S Ali HI; Radwan AG
    J Egypt Med Assoc; 1976; 59(1-2):141-9. PubMed ID: 1032367
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of xanthinol nicotinate treatment on platelet aggregation.
    Seidel G; Endell W
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postoperative thromboembolism by dextran 40, low doses of heparin, or xantinol nicotinate.
    Gruber UF; Duckert F; Fridrich R; Torhorst J; Rem J
    Lancet; 1977 Jan; 1(8005):207-10. PubMed ID: 64746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simultaneous study of the placental, myometrial and cervical circulations (indium 113 and anemometric thermometry). 2. Effect of xanthinol nicotinate].
    Renaud R; Bock A; Chambron J; Rosenthal C; Raffi F; Bidet R; Steinling M
    J Gynecol Obstet Biol Reprod (Paris); 1976 Jun; 5(4):513-7. PubMed ID: 956630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xantinol nicotinate in paralytic poliomyelitis.
    Saksena PN; Malik GK; Tandon OP
    Indian Pediatr; 1979 Dec; 16(12):1081-4. PubMed ID: 541073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the wound-healing effect of benzofuracaine, etaden, and xanthinol nicotinate in an experiment].
    Stepaniuk GI; Ornostaĭ VV; Kozlov VG
    Patol Fiziol Eksp Ter; 1992; (3):16-8. PubMed ID: 1480413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard) (author's transl)].
    Sérey CT; Saling E
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):283-9. PubMed ID: 7008399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.